Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160

Archives of Virology

Volumn 158, Issue 5, 2013, Pages 1013-1019

  Zhu, Wuyang ^a   Fu, Juanjuan ^a   Lu, Jian ^a   Deng, Yao ^a   Wang, Huanqin ^a   Wei, Yan ^a   Deng, Lingling ^a   Tan, Wenjie ^a   Liang, Guodong ^a  

^a National Institute for Viral Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS; MIRIDAE; MUS; SINDBIS VIRUS; SINDBIS-LIKE VIRUS;

EID: 84876723002     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1564-8     Document Type: Article

References (28)

1. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
2. Arribillaga L, Sarobe P, Arina A, Gorraiz M, Borras-Cuesta F, Ruiz J, Prieto J, Chen L, Melero I, Lasarte JJ (2005) Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine 23: 3493-3499.
3. Capone S, Meola A, Ercole BB, Vitelli A, Pezzanera M, Ruggeri L, Davies ME, Tafi R, Santini C, Luzzago A, Fu TM, Bett A, Colloca S, Cortese R, Nicosia A, Folgori A (2006) A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques. J Virol 80: 1688-1699.
4. Ploss A, Dubuisson J (2012) New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut 61: i25-i35.
5. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85: 3173-3188.
6. Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, Pezzanera B, Tafi R, Arcuri M, Fattori E, Lahm A, Luzzago A, Vitelli A, Colloca S, Cortese R, Nicosia A (2006) A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med 12: 190-197.
7. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM, Walker CM (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
8. + T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197: 1645-1655.
9. Shiina M, Rehermann B (2006) Hepatitis C vaccines: inducing and challenging memory T cells. Hepatology 43: 1395-1398.
10. Thimme R, Neumann-Haefelin C, Boettler T, Blum HE (2008) Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine. Biol Chem 389: 457-467.
11. Kirman JR, Turon T, Su H, Li A, Kraus C, Polo JM, Belisle J, Morris S, Seder RA (2003) Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun 71: 575-579.
12. Polo JM, Gardner JP, Ji Y, Belli BA, Driver DA, Sherrill S, Perri S, Liu MA, Dubensky TW Jr (2000) Alphavirus DNA and particle replicons for vaccines and gene therapy. Dev Biol (Basel) 104: 181-185.
13. Perri S, Greer CE, Thudium K, Doe B, Legg H, Liu H, Romero RE, Tang Z, Bin Q, Dubensky TW, JrM Vajdy Jr, Otten GR, Polo JM (2003) An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector. J Virol 77: 10394-10403.
14. + T-Cell responses and cross-neutralizing antibodies against Hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5. J Viro 82: 7492-7503.
15. Zhu WY, Liang GD (2009) Selection and characterization of packaging cell lines for XJ-160 virus. Intervirology 52: 100-104.
16. Zhu WY, Li JJ, Tang L, Wang HQ, Li J, Fu JJ, Liang GD (2011) Glycoprotein is enough for sindbis virus-derived DNA vector to express heterogenous genes. Virol J 8: 344.
17. Bi SL, Bai XH, Cong ME, Liu CB (1993) Sequence analysis and variation in hepatitis C virus isolate from Hebei Province, China. Chin J Virol 9: 114-127.
18. Zhu WY, Yang YL, Fu SH, Wang LH, Zhai YG, Tang Q, Liang GD (2009) Substitutions of 169Lys and 173Thr in nonstructural protein 1 influence the infectivity and pathogenicity of XJ-160 virus. Arch Virol 154: 245-253.
19. Popov VL, Chen SM, Feng HM, Walker DH (1995) Ultrastructural variation of cultured Ehrlichia chaffeensis. J Med Microbiol 43: 411-421.
20. Li C, Liu F, Liang M (2010) Hantaviruslike particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Vaccine 28: 4294-4300.
21. Guan J, Wen B, Deng Y, Zhang K, Chen H, Wu XB, Ruan L, Tan WJ (2011) Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes. Virol J 8: 56.
22. Elmowalid GA, Qiao M, Jeong SH, Jeong SH, Borg BB, Baumert TF, Sapp RK, Hu Z, Muethy K, Liang TJ (2007) Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc Natl Acad Sci USA 104: 8427-8432.
23. Cocquerel L, Kuo CC, Dubuisson J, Levy S (2003) CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol 77: 10677-10683.
24. Garrone P, Fluckiger AC, Mangeot PE, Gauthier E, Dupeyrot-Lacas P, Mancip J, Cangialosi A, Chéné ID, LeGrand R, Mangeot I, Lavillette D, Bellier B, Cosset FL, Tangy F, Klatzmann D, Dalba C (2011) A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques. Sci Transl Med 3: 71.
25. Dahari H, Feinstone SM, Major ME (2010) Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins. Gastroenterol 139: 965-974.
26. Nakata S, Estes MK, Chiba S (1988) Detection of human calicivirus antigen and antibody by enzyme-linked immunosorbent assays. J Clin Microbiol 26: 2001-2005.
27. Sabo MC, Luca VC, Prentoe J, Hopcraft SE, Blight KJ, Yi MK, Lemon SM, Ball JK, Bukh J, Evans MJ, Fremont DH, Diamond MS (2011) Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step. J Virol 85: 7005-7019.
28. Mecchia M, Casato M, Tafi R, Filocamo G, Bonomo L, Fiorilli M, Cortese R, Migliaccio G, Nicosia A (1996) Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 protein. J Immunol 157: 3727-3736.